ALMS
Alumis Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$11.17
−1.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 272.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.20x
- Price / sales
- 195.43x
- Price / cash flow
- -4.11x
Enterprise value
- Enterprise value
- $979.9M
- EV / sales
- 132.46x
- EV / EBITDA
- -2.21x
- EV / EBIT
- -2.13x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026